Citation: Co. Freytes, VASCULAR ACCESS PROBLEMS REVISITED - THE MULTINATIONAL ASSOCIATION OFSUPPORTIVE CARE IN CANCER (MASCC) EXPERIENCE, Supportive care in cancer, 6(1), 1998, pp. 13-19
Authors:
SALEH MN
LEMAISTRE CF
KUZEL TM
FOSS F
PLATANIAS LC
SCHWARTZ G
RATAIN M
ROOK A
FREYTES CO
CRAIG F
REUBEN J
SAMS MW
NICHOLS JC
Citation: Mn. Saleh et al., ANTITUMOR-ACTIVITY OF DAB(389)IL-2 FUSION TOXIN IN MYCOSIS-FUNGOIDES, Journal of the American Academy of Dermatology, 39(1), 1998, pp. 63-73
Authors:
LEMAISTRE CF
SALEH MN
KUZEL TM
FOSS F
PLATANIAS LC
SCHWARTZ G
RATAIN M
ROOK A
FREYTES CO
CRAIG F
REUBEN J
NICHOLS JC
Citation: Cf. Lemaistre et al., PHASE-I TRIAL OF A LIGAND FUSION-PROTEIN (DAB(389)IL-2) IN LYMPHOMAS EXPRESSING THE RECEPTOR FOR INTERLEUKIN-2, Blood, 91(2), 1998, pp. 399-405
Authors:
ANTMAN KH
ROWLINGS PA
VAUGHAN WP
PELZ CJ
FAY JW
FIELDS KK
FREYTES CO
GALE RP
HILLNER BE
HOLLAND HK
KENNEDY MJ
KLEIN JP
LAZARUS HM
MCCARTHY PL
SAEZ R
SPITZER G
STADTMAUER EA
WILLIAMS SF
WOLFF S
SOBOCINSKI KA
ARMITAGE JO
HOROWITZ MM
Citation: Kh. Antman et al., HIGH-DOSE CHEMOTHERAPY WITH AUTOLOGOUS HEMATOPOIETIC STEM-CELL SUPPORT FOR BREAST-CANCER IN NORTH-AMERICA, Journal of clinical oncology, 15(5), 1997, pp. 1870-1879
Authors:
TSAI T
GOODMAN S
SAEZ R
SCHILLER G
ADKINS D
CALLANDER N
WOLFF S
FREYTES CO
Citation: T. Tsai et al., ALLOGENEIC BONE-MARROW TRANSPLANTATION IN PATIENTS WHO RELAPSE AFTER AUTOLOGOUS TRANSPLANTATION, Bone marrow transplantation, 20(10), 1997, pp. 859-863
Authors:
TSAI TW
HAMMOND LA
RINALDI M
MARTIN K
TIO F
MAPLES J
FREYTES CO
ROODMAN GD
Citation: Tw. Tsai et al., COKEROMYCES RECURVATUS INFECTION IN A BONE-MARROW TRANSPLANT RECIPIENT, Bone marrow transplantation, 19(3), 1997, pp. 301-302
Authors:
FREYTES CO
VUKELJA S
SALZMAN D
TSAI T
CALLANDER N
GOKMEN E
RODRIGUEZ T
CASTRO J
BOLDT D
ROODMAN GD
HILSENBECK S
ADKINS D
BACHIER C
CRAIG F
CLARE N
WEISNER A
LEMAISTRE CF
Citation: Co. Freytes et al., AUTOLOGOUS HEMATOPOIETIC STEM-CELL TRANSPLANTATION FOR POOR-PROGNOSISLOW-GRADE LYMPHOMA, Experimental hematology, 24(9), 1996, pp. 629-629
Citation: Co. Freytes et Pg. Beatty, REPRESENTATION OF HISPANICS IN THE NATIONAL MARROW DONOR PROGRAM, Bone marrow transplantation, 17(3), 1996, pp. 323-327
Authors:
GRIFFITHS E
TEAGUE J
HARRISON CR
FREYTES CO
Citation: E. Griffiths et al., HEMOLYSIS DUE TO ANTI-A IN A RECIPIENT OF A MAJOR ABO-INCOMPATIBLE BONE-MARROW TRANSPLANT IN PRESENCE OF A NEGATIVE DIRECT ANTIGLOBULIN-TEST, Blood, 88(10), 1996, pp. 3746-3746
Authors:
VESCIO RA
SCHILLER GJ
STEWART AK
ANDERSON KC
DIPERSIO JF
NOGA SJ
BALLESTER OF
RUGO H
FREYTES CO
WU CH
HAN EJ
CAO J
BELSON DJ
BERENSON JR
Citation: Ra. Vescio et al., QUANTITATIVE ASSESSMENT OF MYELOMA PERIPHERAL-BLOOD AND BONE-MARROW TUMOR BURDEN IN PATIENTS UNDERGOING AUTOLOGOUS TRANSPLANTATION, Blood, 88(10), 1996, pp. 2551-2551
Authors:
TSAI T
SALZMAN D
CLARK G
CASTRO J
CALLANDER N
BOLDT D
ROODMAN GD
SHERIDANLEOS N
WIESNER A
ADKINS D
HARRIS K
RODRIGUEZ T
GOKMEN E
LEMAISTRE CF
FREYTES CO
Citation: T. Tsai et al., AUGMENTED CYCLOPHOSPHAMIDE (C), CARMUSTINE (B) AND ETOPOSIDE (V) + - DACARBAZINE (D) WITH AUTOLOGOUS BONE-MARROW TRANSPLANTATION (BMT) FOR RELAPSED OR REFRACTORY HODGKINS-DISEASE - LOWER PERITRANSPLANT MORTALITY AND ANALYSIS OF PROGNOSTIC FACTORS/, Blood, 86(10), 1995, pp. 3865-3865
Authors:
ADKINS DR
SALZMAN D
BOLDT D
KUHN J
IRVIN R
ROODMAN GD
LYONS R
SMITH L
FREYTES CO
LEMAISTRE CF
Citation: Dr. Adkins et al., PHASE-I TRIAL OF DACARBAZINE WITH CYCLOPHOSPHAMIDE, CARMUSTINE, ETOPOSIDE, AND AUTOLOGOUS STEM-CELL TRANSPLANTATION IN PATIENTS WITH LYMPHOMA AND MULTIPLE-MYELOMA, Journal of clinical oncology, 12(9), 1994, pp. 1890-1901
Authors:
BACHIER C
FREYTES CO
SALZMAN D
CASTRO J
BOLDT D
ROODMAN GD
HARRIS K
CRAIG F
WIESNER A
LEMAISTRE CF
Citation: C. Bachier et al., BONE-MARROW TRANSPLANTATION (BMT) FOR ADULT POOR-RISK HIGH-GRADE NON-HODGKINS-LYMPHOMA (HGNHL), Blood, 84(10), 1994, pp. 10000703-10000703
Authors:
FREYTES CO
BACHIER C
SALZMAN D
VUKELIA S
CASTRO J
BOLDT D
ROODMAN GD
CRAIG F
HARRIS K
TSAI T
SHERIDANLEOS N
HILSENBECK S
TAMI J
BURRELL L
LEMAISTRE CF
Citation: Co. Freytes et al., HIGH-DOSE CHEMOTHERAPY WITH AUTOLOGOUS STEM-CELL RESCUE IN RESISTANT OR RECURRENT LOW-GRADE LYMPHOMA, Blood, 84(10), 1994, pp. 10000709-10000709